Literature DB >> 859534

The ins and outs of oral pancreatic enzymes.

J H Meyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 859534     DOI： 10.1056/NEJM197706092962311

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations.

Authors:  A M Whitehead
Journal:  Pharm Weekbl Sci       Date:  1988-02-19

2.  Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency.

Authors:  C K Abrams; M Hamosh; V S Hubbard; S K Dutta; P Hamosh
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

3.  Studies on the quality of pancreatic preparations: enzyme content, prospective bioavailability, bile acid pattern, and contamination with purines.

Authors:  K H Niessen; J König; M Molitor; B Neef
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

4.  Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis.

Authors:  P L Zentler-Munro; D R Fine; J C Batten; T C Northfield
Journal:  Gut       Date:  1985-09       Impact factor: 23.059

5.  Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis.

Authors:  A Carroccio; F Pardo; G Montalto; L Iapichino; M Soresi; M R Averna; G Iacono; A Notarbartolo
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

6.  Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.

Authors:  N Peretti; V Marcil; E Drouin; E Levy
Journal:  Nutr Metab (Lond)       Date:  2005-05-03       Impact factor: 4.169
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.